← Research LibraryThe BriefFY2026 10-K · headline figures audited against SEC data
SAIC's revenue and profit declined, but free cash flow improved and remained substantial, preserving flexibility through a softer government-contract year.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 2.9%Watch
- Profitability — Net income declined 1.1% to $358M from $362MWatch
- Cash flow — Free cash flow grew 26.0% to $577M from $458MOK
- Margins — Operating margin contracted 36 bps to 7.17%Watch
- Accounting — Government contraction with resilient cash flowNote
- Insiders — 7 purchases and 0 salesOK
Business
SAIC provides engineering, digital, artificial-intelligence and mission-support services to U.S. government customers.
Where the revenue comes from
Fiscal 2026, as Science Applications International Corp reports it. History and quarterly detail are in the app.
- Defense and Intelligence$5.6B
- Civilian$1.7B
Leadership changes
From Science Applications International Corp's own filings, the day they're filed.
- Admiral Michael Rogers · Directors · departureeff. 2026-04-09
- Paul Eremenko · Directors · departureeff. 2026-04-09
- James C. Reagan · Chief Executive Officer · appointmenteff. 2026-02-17
Latest filings
- 10-Q · Quarterly report2026-08-31
- 8-K · Company announcement2026-08-31
- 8-K · Company announcement2026-08-28
- 8-K · Company announcement2026-08-19
- 8-K · Company announcement2026-08-10
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Science Applications International Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.